Literature DB >> 22743965

Anticancer TLR agonists on the ropes.

Malini Guha.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22743965     DOI： 10.1038/nrd3775

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  24 in total

1.  Toll-like receptor agonist rMBP-NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer.

Authors:  Cong Ding; Li Li; Yi Zhang; Zhenyu Ji; Chenglong Zhang; Taotao Liang; Xun Guo; Xin Liu; Qiaozhen Kang
Journal:  Oncol Lett       Date:  2018-07-20       Impact factor: 2.967

2.  Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.

Authors:  Chiara Castelli; Frédéric Triebel; Licia Rivoltini; Chiara Camisaschi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

Review 3.  Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors.

Authors:  Sudhir Agrawal; Ekambar R Kandimalla
Journal:  Immunooncol Technol       Date:  2019-10-16

4.  Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.

Authors:  Mingye Feng; James Y Chen; Rachel Weissman-Tsukamoto; Jens-Peter Volkmer; Po Yi Ho; Kelly M McKenna; Samuel Cheshier; Michael Zhang; Nan Guo; Phung Gip; Siddhartha S Mitra; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 5.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

Review 6.  The Yin and Yang of Toll-like receptors in cancer.

Authors:  J-P Pradere; D H Dapito; R F Schwabe
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

7.  Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists.

Authors:  Kui Cheng; Meng Gao; James I Godfroy; Peter N Brown; Noah Kastelowitz; Hang Yin
Journal:  Sci Adv       Date:  2015       Impact factor: 14.136

8.  Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models.

Authors:  Jared S Klarquist; Edith M Janssen
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

9.  Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.

Authors:  Hugo Gagnon; Sarah Refaie; Sandra Gagnon; Roxane Desjardins; Michel Salzet; Robert Day
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 10.  Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation.

Authors:  Anuradha Ray; Krishnendu Chakraborty; Prabir Ray
Journal:  Front Cell Infect Microbiol       Date:  2013-09-18       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.